tallactherapeutics.com valuation and analysis

Robots.txt Information
Robot Path Permission
GoogleBot / ✔
BingBot / ✔
BaiduSpider / ✔
YandexBot / ✔ 
User-agent: * Disallow: /wp-admin/ Allow: /wp-admin/admin-ajax.php Sitemap:
Meta Tags
Title Tallac Therapeutics, Inc – Landing
Description Harnessing the power of innate and adaptive immunity to fight Harnessing the power of innate and adaptive immunity to fight cancer About US Tallac Therapeutics™, founded in 2018 is a privately held biopharmaceutical
Keywords N/A
Server Information
WebSite tallactherapeutics favicontallactherapeutics.com
Host IP 173.236.195.169
Location United States
Related Websites
Site Rank
More to Explore
tallactherapeutics.com Valuation
US$6,938,725
Last updated: 2023-05-09 11:37:17

tallactherapeutics.com has Semrush global rank of 1,525,396. tallactherapeutics.com has an estimated worth of US$ 6,938,725, based on its estimated Ads revenue. tallactherapeutics.com receives approximately 800,623 unique visitors each day. Its web server is located in United States, with IP address 173.236.195.169. According to SiteAdvisor, tallactherapeutics.com is safe to visit.

Traffic & Worth Estimates
Purchase/Sale Value US$6,938,725
Daily Ads Revenue US$6,405
Monthly Ads Revenue US$192,150
Yearly Ads Revenue US$2,305,792
Daily Unique Visitors 53,375
Note: All traffic and earnings values are estimates.
DNS Records
Host Type TTL Data
tallactherapeutics.com. A 298 IP: 173.236.195.169
tallactherapeutics.com. NS 300 NS Record: ns2nsy.name.com.
tallactherapeutics.com. NS 300 NS Record: ns3fgq.name.com.
tallactherapeutics.com. NS 300 NS Record: ns4kpx.name.com.
tallactherapeutics.com. NS 300 NS Record: ns1hwy.name.com.
HtmlToTextCheckTime:2023-05-09 11:37:17
Harnessing the power of innate and adaptive immunity to fight cancer About US Tallac Therapeutics™, founded in 2018 is a privately held biopharmaceutical company based in the San Francisco Bay Area. Our multi-disciplinary team is rapidly advancing the company’s lead programs in cancer toward clinical trials in multiple indications. Read more Science Despite the success of checkpoint inhibitors and adoptive CAR-T therapies, only a fraction of cancer patients benefit. Novel therapies engaging both innate and adaptive immune response may produce more robust and durable anti-cancer immunity. We developed a novel Toll-like Receptor Agonist Antibody Conjugate (TRAAC) platform to deliver a potent TLR9 agonist (T-CpG) for targeted immune activation via systemic administration. We are advancing a pipeline of therapies that enable innovative therapeutic approaches for multiple solid tumor malignancies. Read more News We are excited to share our latest news and scientific publications. Latest
HTTP Headers
HTTP/1.1 301 Moved Permanently
Date: Sun, 31 Oct 2021 19:24:29 GMT
Server: Apache
Location: https://www.tallactherapeutics.com/
Content-Type: text/html; charset=iso-8859-1

HTTP/2 200 
date: Sun, 31 Oct 2021 19:24:30 GMT
server: Apache
expires: Thu, 19 Nov 1981 08:52:00 GMT
cache-control: no-store, no-cache, must-revalidate
pragma: no-cache
link: ; rel="https://api.w.org/", ; rel="alternate"; type="application/json", ; rel=shortlink
set-cookie: PHPSESSID=3302307396253aa83b0d094d5f3b94f3; path=/
vary: User-Agent
content-type: text/html; charset=UTF-8
tallactherapeutics.com Whois Information
Domain Name: TALLACTHERAPEUTICS.COM
Registry Domain ID: 2539839506_DOMAIN_COM-VRSN
Registrar WHOIS Server: whois.name.com
Registrar URL: http://www.name.com
Updated Date: 2020-06-18T21:02:11Z
Creation Date: 2020-06-18T21:02:11Z
Registry Expiry Date: 2022-06-18T21:02:11Z
Registrar: Name.com, Inc.
Registrar IANA ID: 625
Registrar Abuse Contact Email: abuse@name.com
Registrar Abuse Contact Phone: 7202492374
Domain Status: clientTransferProhibited https://icann.org/epp#clientTransferProhibited
Name Server: NS1HWY.NAME.COM
Name Server: NS2NSY.NAME.COM
Name Server: NS3FGQ.NAME.COM
Name Server: NS4KPX.NAME.COM
DNSSEC: unsigned
>>> Last update of whois database: 2021-09-19T05:12:11Z <<<

Copyright © 2022 WebZZ.US 0.0183